Pharmacy, Categories of Drugs and Drug Action (ICPCDDA-27)

This track focuses on the latest research in pharmacology, emphasizing the mechanisms of drug action and their therapeutic implications. Participants will explore novel pharmacological agents and their potential applications in clinical settings.

This session will delve into the synthesis, design, and characterization of pharmaceutical compounds. Discussions will highlight the role of chemical structures in determining drug efficacy and safety.

This track addresses the integration of clinical pharmacology into direct patient care practices. It aims to enhance understanding of personalized medicine and the optimization of therapeutic regimens.

Focusing on the pharmacological effects on the nervous system, this session will cover the latest findings in neuropharmacology. Topics will include the role of neurotransmitters and the development of neuroactive drugs.

This track will explore the principles of pharmacodynamics and pharmacokinetics in drug development and clinical application. Participants will discuss how these concepts influence drug efficacy and safety profiles.

This session will focus on the assessment of drug toxicity and its implications for patient safety. Discussions will include the evaluation of adverse drug reactions and the role of toxicology in drug development.

This track will highlight the importance of laboratory medicine in diagnosing and monitoring drug therapy. Participants will explore advancements in molecular diagnostics and their impact on patient outcomes.

This session will examine the therapeutic potential of natural products and their bioactive compounds. Discussions will focus on the mechanisms of action and the role of these substances in modern medicine.

This track will explore the intersection of chemical biology and pharmacology in the discovery of new therapeutic agents. Participants will discuss innovative approaches to drug design and development.

This session will focus on the evolving role of pharmacy practice within the healthcare system. Discussions will include strategies for enhancing collaboration among healthcare professionals to improve patient care.

This track will address the latest developments in psychopharmacology, focusing on the treatment of mental health disorders. Participants will explore the efficacy and safety of new psychotropic medications and their mechanisms of action.